Form 4: Enfusion General Counsel Matthew Campobasso Reports Disposal of Shares Following Merger with Clearwater Analytics

Matthew Campobasso, General Counsel of Enfusion, Inc., reports the disposal of shares following the company's merger with Clearwater Analytics Holdings, Inc.

Summary

• Matthew Campobasso, General Counsel of Enfusion, Inc., filed a Form 4 indicating changes in beneficial ownership due to the merger with Clearwater Analytics Holdings, Inc.
• The merger agreement, dated January 10, 2025, involved Clearwater Analytics Holdings, Inc. and several subsidiaries.
• Eligible shares of Enfusion's Class A common stock were converted into the right to receive cash, shares of Clearwater Analytics's Class A common stock, or a combination thereof.
• Campobasso disposed of 25,147 shares of Common Stock and shares underlying vested restricted stock units (RSUs) of Enfusion, which were converted into the right to receive the merger consideration.
• Additionally, 45,799 shares of Common Stock underlying unvested RSUs of Enfusion were converted into Parent RSUs.
• As a result of the merger, Campobasso ceased to be a beneficial owner of any securities of Enfusion, marking this as an exit filing.

Sentiment

Score: 7

Explanation: The sentiment is neutral as it reflects a standard transaction following a merger agreement. There are no indications of distress or exceptional performance, just the execution of a pre-defined plan.

Industry Context

This announcement reflects a consolidation trend within the financial technology sector, where companies are merging to expand their service offerings and market reach. Clearwater Analytics's acquisition of Enfusion aligns with this trend, potentially creating a more comprehensive platform for investment management.

Stakeholder Impact

• Shareholders of Enfusion received consideration in the form of cash or Clearwater Analytics shares.
• Employees of Enfusion may experience changes as a result of the merger.
• The merger could lead to changes in the services and offerings available to customers of both Enfusion and Clearwater Analytics.

Key Dates

Keywords

Form 4, Enfusion, Clearwater Analytics, Merger, Beneficial Ownership, Campobasso, Securities